VeriMomfisetin hamilelikte güvenli mi?
No harmonised CLP (ECHA Annex VI) or SCCS/CIR reproductive/teratogenic classification for fisetin was identified in the authoritative sources searched; peer‑reviewed animal studies did not report teratogenicity and in some pregnancy models fisetin was protective (e.g., preeclampsia‑like rat model and mitigation of methylmercury developmental neurotoxicity). Some in vitro and in vivo work shows interaction with estrogen and androgen signalling (ER/AR modulation), but there is no evidence of a reproductive mechanism causing human/animal developmental toxicity. Given its molecular size and physicochemistry there is potential for low but measurable dermal absorption from topical use. Sources: PubMed studies and ECHA/C&L/SDS listings (self‑notifications exist in some supplier SDSs but these are not harmonised CLH and per your instruction do not raise hazard score).
Pregnancy-safe products containing fisetin
Related ingredients
Frequently asked questions
- fisetin hamilelikte güvenli mi?
- No harmonised CLP (ECHA Annex VI) or SCCS/CIR reproductive/teratogenic classification for fisetin was identified in the authoritative sources searched; peer‑reviewed animal studies did not report teratogenicity and in some pregnancy models fisetin was protective (e.g., preeclampsia‑like rat model and mitigation of methylmercury developmental neurotoxicity). Some in vitro and in vivo work shows interaction with estrogen and androgen signalling (ER/AR modulation), but there is no evidence of a reproductive mechanism causing human/animal developmental toxicity. Given its molecular size and physicochemistry there is potential for low but measurable dermal absorption from topical use. Sources: PubMed studies and ECHA/C&L/SDS listings (self‑notifications exist in some supplier SDSs but these are not harmonised CLH and per your instruction do not raise hazard score).
- fisetin emzirirken güvenli mi?
- No authoritative safety assessment (CIR or SCCS) or harmonised classification indicating harm to breastfed children was found. No controlled human data showing transfer into milk or adverse effects in suckling offspring; some animal pregnancy studies showed protective effects rather than toxicity. Dermal exposure from cosmetics would be expected to give low but measurable systemic exposure in adults, so a low exposure score is used. Self‑classified SDS statements claiming reproductive/breastfeeding hazard are present for some supplier documents but are not equivalent to harmonised CLH and were not used to increase the hazard score.
- fisetin bebek cildi için güvenli mi?
- No infant‑specific hazard evidence was identified. Per the scoring rules, because fisetin shows measurable dermal absorption in principle (small flavonol) the exposure score for baby skin is increased by +1 relative to adults to account for immature barrier and higher surface‑area‑to‑weight; there is no direct data showing increased hazard or infant‑specific mechanism, so hazard and mechanism scores remain at default.
- VeriMom fisetin nasıl puanlıyor?
- VeriMom fisetin'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte fisetin yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.